Vertex Pharmaceuticals VRTX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's invested capital?
- Vertex Pharmaceuticals (VRTX) reported invested capital of $15.84B in Q1 2026.
- How has Vertex Pharmaceuticals's invested capital changed year-over-year?
- Vertex Pharmaceuticals's invested capital increased by 17.7% year-over-year, from $13.46B to $15.84B.
- What is the long-term trend for Vertex Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's invested capital has grown at a 18.0% compound annual growth rate (CAGR), from $6.83B to $15.61B.
- What does invested capital mean?
- The capital — debt plus equity, net of idle cash — that funds the operating business.
- How do you interpret invested capital?
- A level, read mainly through ROIC (NOPAT ÷ invested capital). Growing invested capital is only good if returns on it stay above the cost of capital.
- How does invested capital compare across companies?
- Used as the base for ROIC; the definition is sector-sensitive, so banks and insurers are best excluded.